急性冠脉综合征患者血清胱抑素C,同型半胱氨酸和急性时相C反应蛋白水平及其影响因素研究

吕国龄, 霍正禄

吕国龄, 霍正禄. 急性冠脉综合征患者血清胱抑素C,同型半胱氨酸和急性时相C反应蛋白水平及其影响因素研究[J]. 实用临床医药杂志, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004
引用本文: 吕国龄, 霍正禄. 急性冠脉综合征患者血清胱抑素C,同型半胱氨酸和急性时相C反应蛋白水平及其影响因素研究[J]. 实用临床医药杂志, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004
LV Guoling, HUO Zhenglu. Study on the levels and influencing factors of serum cystatin C, homocysteine and acute phase C reactive protein in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004
Citation: LV Guoling, HUO Zhenglu. Study on the levels and influencing factors of serum cystatin C, homocysteine and acute phase C reactive protein in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004

急性冠脉综合征患者血清胱抑素C,同型半胱氨酸和急性时相C反应蛋白水平及其影响因素研究

基金项目: 中国高校医学期刊临床专项资金
详细信息
  • 中图分类号: R541

Study on the levels and influencing factors of serum cystatin C, homocysteine and acute phase C reactive protein in patients with acute coronary syndrome

  • 摘要: 目的 探讨血清胱抑素C(Cystatin C)、同型半胱氨酸(Hcy)和急性时相C反应蛋白(Hs-CRP)在急性冠脉综合征患者血清中的水平及其影响因素.方法 急性心肌梗死患者30例为急性心梗组,不稳定心绞痛患者35例为不稳定心绞痛组,排除冠心病诊断的患者20例为对照组.检测3组患者血清中Cystatin C、Hs-CRP、Hcy水平.同时检测3组患者血低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、甘油三酯(TG)、总胆固醇(Tc)的水平,并记录患者高血压病史、糖尿病史、目前吸烟史等情况.结果 急性心梗组和不稳定心绞痛组的Hs-CRP、Hcy水平明显高于对照组,LDL、HDL水平明显低于对照组;急性心梗组CystatinC、TC水平明显低于对照组;不稳定心绞痛组CystatinC水平明显高于对照组;各组TG水平无显著差异.糖尿病、吸烟史、高血压史对Hcy水平变化均有影响,对Hs-CRP、Cystatin C水平变化无影响.结论 急性冠脉综合征患者血清Hcy、HsCRP、Cystatin C浓度变化在一定程度上反映了动脉粥样斑块的稳定性.
  • Yu H, Rifai N A. High-sensitivity C reactive protein and atherosclerosis:from theory to therapy [J]. Clinical Biochemistry, 2000(8):601.
    Homocysteine Studies Collaboration. Homocysteine and risk of ischemiC heart disease and stroke:a meta-analysis [J]. Journal of the American Medical Association, 2002, (16):2015.
    Dr Minno G, Anvi G, Margagtion M. Abnormally high thromboxane biosynthesis in homocysteinuria:Evidence for Platelet involvement and probucolsensice mechanism [J]. Journal of Clinical Investigation, 1993(3):1400.
    Matthias D, Becker C H, Riezler R. Homocysteine induced arteriosclerosisilike alternations of the aorta in normotensive and hypertensive rata following application of high doses of methinnine [J]. Atheroclerosis, 1996(2):201.
    Varo N, Libhy P, de Lemo s J A. Soluble CD40L risk prediction after acute coronary syndromes [J]. Circulation, 2003(9):1049.
    Du Clos T W. Function of C-reaction protein [J]. Annals of Medicine, 2000(3):274.
    Pascrei V, Chang J, WillersonJ T. Modulation of C-reactive protein mediated monocyte chmoattractant protein-1 induction in human endothelial eells by anti-atherosclerosis drugs [J]. Circulation, 2001, (21):2531.
    Park W C. Who are the proteolytic culprits in vascular di sease [J]. Journal of Clinical Investigation, 1999(9):1167.
    Davide Noto, Angelo Baldassare Cefalu, Carlo Maria Barbagallo. Cystatin C leveI S are decreased in acute myocardial infarction Effect of Cystatin C G73A gene polymorphism on plasma 1 evels [J]. International Journal of Cardiology, 2005(2):213.
    Koyner J L, Garg A X, Shlipak M G. Urinary cystatin C and acute kidney injury after cardiac surgery [J]. American Journal of Kidney Diseases, 2013(5):730.
    Fouad M, Boraie M. Cystatin C as an early marker of acute kidney injury and predictor of mortality in the intensive care unit after acute myocardial infarction [J]. Arab J Nephrol Transplant, 2013(1):21.
    Ristiniemi N, Lund J, Tertti R. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome [J]. Clinical Biochemistry, 2012, (7/8):535.
计量
  • 文章访问数:  130
  • HTML全文浏览量:  21
  • PDF下载量:  8
  • 被引次数: 0
出版历程
  • 发布日期:  2013-10-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭